GAURAV AGGARWAL, M.D.

Corporate Board Profile

Tech Score: 0/100

GERON CORP

Filing Date	Source Excerpt
2024-03-27	Gaurav Aggarwal, M.D. has served as a director of Geron since November 2023. The Board believes Dr. Aggarwal’s extensive experience as an investor in the life sciences sector, as well as his experience with the evaluation of strategic decision making for life sciences companies as a member of the investment community, provides great value to the Board and contributes significantly to discussions and decision-making, which qualifies him to serve as a director. For the year ended December 31, 2023, Dr. Aggarwal received $4,157 in cash fees and $286,660 in stock option awards, totaling $290,817.
2025-04-08	Gaurav Aggarwal, M.D. has served as a director of Geron since November 2023. ... The current members of the Compensation Committee are Dr. Aggarwal, Dr. Spiegel, and Dr. Molineaux. ... Dr. Aggarwal, Ms. O’Farrell and Mr. McDonald are the current members of the Strategic Committee and served on the Strategic Committee for the year ended December 31, 2024. Dr. Aggarwal serves as Chair of the Strategic Committee.

Filing Date

Source Excerpt

2024-03-27

Gaurav Aggarwal, M.D. has served as a director of Geron since November 2023. The Board believes Dr. Aggarwal’s extensive experience as an investor in the life sciences sector, as well as his experience with the evaluation of strategic decision making for life sciences companies as a member of the investment community, provides great value to the Board and contributes significantly to discussions and decision-making, which qualifies him to serve as a director. For the year ended December 31, 2023, Dr. Aggarwal received $4,157 in cash fees and $286,660 in stock option awards, totaling $290,817.

2025-04-08

Gaurav Aggarwal, M.D. has served as a director of Geron since November 2023. ... The current members of the Compensation Committee are Dr. Aggarwal, Dr. Spiegel, and Dr. Molineaux. ... Dr. Aggarwal, Ms. O’Farrell and Mr. McDonald are the current members of the Strategic Committee and served on the Strategic Committee for the year ended December 31, 2024. Dr. Aggarwal serves as Chair of the Strategic Committee.

Data sourced from SEC filings. Last updated: 2026-02-03